DavidJasonGallagherMD

PubMed

• 2 citations
  The contribution of Lynch syndrome to early onset malignancy in Ireland
  Alice Talbot, Emily O'Donovan, Eileen Berkley, Carmel Nolan, Roisin Clarke, David J. Gallagher> ;BMC Cancer. 2021 May 26
• 6 citations
  Insertion of an SVA element in MSH2 as a novel cause of Lynch syndrome.
  Ciyu Yang, Yirong Li, Magan Trottier, Michael P. Farrell, Vikas Rai, Erin E. Salo-Mullen, David J. Gallagher, Zsofia K. Stadler, Heleen M. van der Klift, Liying Zhang> ;Genes, Chromosomes & Cancer. 2021 Apr 6
• 14 citations
  Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
  Elizabeth Bancroft, Sibel Saya, Emma Brown, Sarah Thomas, Natalie Taylor, Jeanette Rothwell, Jennifer Pope, Anthony Chamberlain, Elizabeth Page, Sarah Benafif, Helen H...> ;Journal of Medical Genetics. 2020 Apr 1
• 128 citations
  Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
  Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Rag...> ;European Urology. 2019 Dec 1
• 7 citations
  Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes.
  C. Thompson, Ciara McCormick, Waseem Kamran, Ciaran O'Riain, Lucy A. Norris, David J. Gallagher, Noreen Gleeson> ;Irish Journal of Medical Science. 2018 Jan 3
• 4 citations
  Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
  Christos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, Elizabeth Bancroft, Emily Vertosick, Tokhir Dadaev, Charles Brendler, Elizabeth Page, Alexander Dias, D G...> ;British Journal of Cancer. 2018 Jan 1
• 6 citations
  Next generation sequencing is informing phenotype: a TP53 example.
  R. O’Shea, Roisin Clarke, E. Berkley, C. Giffney, Michael P. Farrell, E. O’Donovan, David J. Gallagher> ;Familial Cancer. 2018 Jan 1
• 3 citations
  High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.
  Margaret Walshe, Robert Moran, Marie Boyle, Ion Cretu, Zita Galvin, Victoria Swan, Jason Trikovic, Michael P. Farrell, Sinéad Foy, Loretta O’Brien, J Leyden, Niall Mul...> ;Cancer Epidemiology. 2017 Oct 1
• 5 citations
  Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series
  Terri P. McVeigh, Nuala Cody, Cliona Carroll, Marie Duff, Michael P. Farrell, Lisa Bradley, David J. Gallagher, Trudi McDevitt, Andrew Green> ;Cancer Genetics. 2017 Aug 1
• 26 citations
  Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.
  Grainne M. O'Kane, Éanna J Ryan, Terri P. McVeigh, Ben Creavin, John Hyland, Diarmuid O'Donoghue, Denise Keegan, Robert Geraghty, Delia Flannery, Carmel Nolan, Emily D...> ;Cancer Medicine. 2017 Feb 1
• 46 citations
  Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.
  Sibel Saya, Emma Killick, S. Thomas, Natalie Taylor, Elizabeth Bancroft, Jeanette Rothwell, Sarah Benafif, Alexander Dias, Christos Mikropoulos, Jennifer Pope, Anthony...> ;Familial Cancer. 2017 Jan 16
• 1 citations
  MUTYH-Associated Polyposis: The Irish Experience>.
  Terri P. McVeigh, Duff M, Cliona Carroll, R. O’Shea, Lisa Bradley, Michael P. Farrell, David J. Gallagher, C Clabby, Andrew Green> ;Irish Medical Journal. 2016 Dec 12
• 1 citations
  Diagnosing Lynch Syndrome.
  J Gleeson, David J. Gallagher> ;Irish Medical Journal. 2016 Dec 12
• 6 citations
  A qualitative analysis of the attitudes of Irish patients towards participation in genetic-based research
  Terri P. McVeigh, Karl J. Sweeney, Michael J. Kerin, David J. Gallagher> ;Irish Journal of Medical Science. 2016 Nov 1
• Genetic testing and interpretive complexity: a BRCA1 gene mutation example
  D. S. Gogarty, M. P. Farrell, David J. Gallagher> ;Irish Journal of Medical Science. 2016 Nov 1
• 2 citations
  Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study
  Elaine M. Walsh, Michael Farrell, Carmel Nolan, F. Gallagher, Roisin Clarke, John McCaffrey, M. J. Kennedy, Mitchel Barry, Malcolm R. Kell, David J. Gallagher> ;Irish Journal of Medical Science. 2016 Feb 1
• 31 citations
  An Overview of Triple Negative Breast Cancer for Surgical Oncologists
  Shiva Sharma, Mitchel Barry, David J. Gallagher, Malcolm R. Kell, Virgilio Sacchini> ;Surgical Oncology. 2015 Sep 1
• 11 citations
  An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality
  John F. Sullivan, Ryan P. Kopp, Kelly L. Stratton, Christopher Manschreck, Marina Corines, Rohini Rau-Murthy, James E. Hayes, A Lincon, Asad Ashraf, Tinu Thomas, Kasmi...> ;British Journal of Cancer. 2015 Jun 30
• 21 citations
  Is Distal Locking Necessary? A Biomechanical Investigation of Intramedullary Nailing Constructs for Intertrochanteric Fractures
  David Gallagher, Brock Adams, Hebah El-Gendi, Ashish Patel, Lauren Grossman, Jay Berdia, Yevgeniy Korshunov, Ariel Goldman> ;Journal of Orthopaedic Trauma. 2013 Jul 1
• 2 citations
  Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.
  Michael Farrell, David J. Hughes, Mark Drost, Andrew J Wallace, Robert Cummins, T. A. Fletcher, Marie Meany, Elaine W. Kay, N. de Wind, Derek G. Power, E. J. Andrews, ...> ;Familial Cancer. 2013 May 28
• 4 citations
  Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome
  Michael Farrell, David J. Hughes, Ian R. Berry, David J. Gallagher, Emily Glogowski, S. J. Payne, M. J. Kennedy, Roisin Clarke, Susan A. White, Cian B. Muldoon, Fiona ...> ;Familial Cancer. 2012 Jul 7
• 34 citations
  Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer
  David J. Gallagher, Angel M. Cronin, Matthew I. Milowsky, Michael J. Morris, Jasmine Bhatia, Peter T. Scardino, James A. Eastham, Kenneth Offit, Mark E. Robson> ;BJU International. 2012 Mar 1
• 8 citations
  Genetic architecture of prostate cancer in the Ashkenazi Jewish population.
  Joseph Vijai, Tomas Kirchhoff, David J. Gallagher, N Hamel, Saurav Guha, Ariel Darvasi, Todd Lencz, William D. Foulkes, Kenneth Offit, Robert J. Klein> ;British Journal of Cancer. 2011 Sep 6
• 15 citations
  Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response
  David J. Gallagher, Hikmat Al-Ahmadie, Irina Ostrovnaya, Scott R. Gerst, Ashley Marie Regazzi, Ilana Rebecca Garcia-Grossman, Jamie Riches, Sivaraman K. Gounder, Anne ...> ;European Urology. 2011 Aug 1
• 37 citations
  Hypoxia‐inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications
  Satish K. Tickoo, Matthew I. Milowsky, Nitin Dhar, Maria E. Dudas, David J. Gallagher, Hikmat Al-Ahmadie, Anuradha Gopalan, Samson W. Fine, Nicole Ishill, Dean F. Bajo...> ;BJU International. 2011 Mar 1
• Join now to see all